Back to search
Myelo Dysplastic Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelo Dysplastic Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelo Dysplastic Syndrome trials you may qualify forto investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), monocytopenia, hy…
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 administered to patients with relapsed, refractory hematologic malignancies, includin…
The primary objective of this trial is as follows: To determine the pharmacokinetics of micafungin given twice weekly in patients at risk for developing an inv…